Caspase Inhibition Activates HIV in Latently Infected Cells
Open Access
- 1 May 2002
- journal article
- Published by Elsevier
- Vol. 277 (18) , 15459-15464
- https://doi.org/10.1074/jbc.m200763200
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The number of HIV DNA-infected mononuclear cells is reduced under HAART plus recombinant IL-2Antiviral Research, 2000
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999
- Signalling by CD95 and TNF receptors: Not only life and deathImmunology & Cell Biology, 1999
- HIV-1 LTR Activity in Human CD40-Activated B Lymphocytes Is Dependent on NF-κBBiochemical and Biophysical Research Communications, 1996
- Regulation of HIV-1 Long Terminal Repeats by Interaction of C/EBP(NF-IL6) and NF-κB/Rel Transcription FactorsPublished by Elsevier ,1996
- The CD95 (APO-1/Fas) Receptor Activates NF- B Independently of Its Cytotoxic FunctionPublished by Elsevier ,1996
- Protease activation during apoptosis: Death by a thousand cuts?Cell, 1995
- FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosisCell, 1995
- The Fas Death FactorScience, 1995
- Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.Proceedings of the National Academy of Sciences, 1989